Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Link
http://link.springer.com/content/pdf/10.1007/s40265-017-0720-6.pdf
Reference61 articles.
1. Bethoux F, Marrie RA. A cross-sectional study of the impact of spasticity on daily activities in multiple sclerosis. Patient. 2016;9(6):537–46.
2. Vermersch P. MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study. Neurodegener Dis Manag. 2014;4(6):407–15.
3. Zettl UK, Rommer P, Hipp P, et al. Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis. Ther Adv Neurol Disord. 2016;9(1):9–30.
4. GW Pharma Ltd. Sativex (delta-9-tetrahydrocannabinol/cannabidiol) oromucosal spray: UK summary of product characteristics. 2015. http://www.medicines.org.uk/emc/medicine/23262 . Accessed 20 Jan 2017.
5. Guy GW, Stott CG. The development of Sativex®: a natural cannabis-based medicine. In: Mechoulam R, editor. Cannabinoids as Therapeutics. Basel: Birkhäuser Basel; 2005. p. 231–63.
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cannabis sativa in Phytotherapy: Reappraisal of Therapeutic Potential and Regulatory Aspects;Current Pharmaceutical Biotechnology;2024-01
2. Should oncologists trust cannabinoids?;Frontiers in Pharmacology;2023-07-13
3. Can cannabidiol (CBD) help with low back pain?;Annals of Agricultural and Environmental Medicine;2023-07-12
4. Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review;Pharmaceutics;2023-07-05
5. Neuroprotective Effect of a Pharmaceutical Extract of Cannabis with High Content on CBD Against Rotenone in Primary Cerebellar Granule Cell Cultures and the Relevance of Formulations;Cannabis and Cannabinoid Research;2023-05-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3